Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population

Background Sepsis likely contributes to the high burden of infectious disease morbidity and mortality in low income countries. Data regarding sepsis management in sub-Saharan Africa are limited. We conducted a prospective observational study reporting the management and outcomes of severely septic patients in two Ugandan hospitals. We describe their epidemiology, management, and clinical correlates for mortality. Methodology/Results Three-hundred eighty-two patients fulfilled enrollment criteria for a severe sepsis syndrome. Vital signs, management and laboratory results were recorded. Outcomes measured included in-hospital and post-discharge mortality. Most patients were HIV-infected (320/377, 84.9%) with a median CD4+ T cell (CD4) count of 52 cells/mm3 (IQR, 16–131 cells/mm3). Overall mortality was 43.0%, with 23.7% in-hospital mortality (90/380) and 22.3% post-discharge mortality (55/247). Significant predictors of in-hospital mortality included admission Glasgow Coma Scale and Karnofsky Performance Scale (KPS), tachypnea, leukocytosis and thrombocytopenia. Discharge KPS and early fluid resuscitation were significant predictors of post-discharge mortality. Among HIV-infected patients, CD4 count was a significant predictor of post-discharge mortality. Median volume of fluid resuscitation within the first 6 hours of presentation was 500 mLs (IQR 250–1000 mls). Fifty-two different empiric antibacterial regimens were used during the study. Bacteremic patients were more likely to die in hospital than non-bacteremic patients (OR 1.83, 95% CI = 1.01–3.33). Patients with Mycobacterium tuberculosis (MTB) bacteremia (25/249) had higher in-hospital mortality (OR 1.97, 95% CI = 1.19–327) and lower median CD4 counts (p = 0.001) than patients without MTB bacteremia. Conclusion Patients presenting with sepsis syndromes to two Ugandan hospitals had late stage HIV infection and high mortality. Bacteremia, especially from MTB, was associated with increased in-hospital mortality. Most clinical predictors of in-hospital mortality were easily measurable and can be used for triaging patients in resource-constrained settings. Procurement of low cost and high impact treatments like intravenous fluids and empiric antibiotics may help decrease sepsis-associated mortality in resource-constrained settings.

[1]  N. Groce,et al.  Surviving sepsis in low-income and middle-income countries: new directions for care and research. , 2009, The Lancet. Infectious diseases.

[2]  N. Kenya-Mugisha,et al.  Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria. , 2009, The American journal of tropical medicine and hygiene.

[3]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[4]  S. Keenan,et al.  A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry* , 2009, Critical care medicine.

[5]  T. West,et al.  Strategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing Countries , 2008, PLoS medicine.

[6]  M. Molyneux,et al.  Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Reynolds,et al.  Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[9]  B Sharma,et al.  Thrombocytopenia in Septic Shock Patients—A Prospective Observational Study of Incidence, Risk Factors and Correlation with Clinical Outcome , 2007, Anaesthesia and intensive care.

[10]  A. Awad,et al.  Self-Medication Practices with Antibiotics and Antimalarials Among Sudanese Undergraduate University Students , 2007, The Annals of pharmacotherapy.

[11]  S. Harthug,et al.  Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study , 2007, BMC infectious diseases.

[12]  H. Ullum,et al.  Predictors of Mortality in a Cohort of HIV-1-Infected Adults in Rural Africa , 2007, Journal of acquired immune deficiency syndromes.

[13]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[14]  M. Dünser,et al.  A review and analysis of intensive care medicine in the least developed countries* , 2006, Critical care medicine.

[15]  Cathy A Petti,et al.  Laboratory medicine in Africa: a barrier to effective health care. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  F. Wabwire-mangen,et al.  HIV Counseling and Testing Practices at an Urban Hospital in Kampala, Uganda , 2006, AIDS and Behavior.

[17]  L. McIntyre,et al.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity , 2005, Canadian Medical Association Journal.

[18]  J. Kublin,et al.  A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management , 2004, Tropical medicine & international health : TM & IH.

[19]  D. Ross-Degnan,et al.  A comparison of prescribing practices between public and private sector physicians in Uganda. , 2004, East African medical journal.

[20]  R. O. Adome,et al.  Community pharmaceutical care: an 8-month critical review of two pharmacies in Kampala. , 2003, African health sciences.

[21]  Corinne Alberti,et al.  Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. , 2003, American journal of respiratory and critical care medicine.

[22]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[23]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[24]  Djillali Annane,et al.  Reducing mortality in sepsis: new directions , 2002, Critical care.

[25]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[26]  S. Kariuki,et al.  Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[28]  L. Reller,et al.  Clinical microbiology in developing countries. , 2001, Emerging infectious diseases.

[29]  T. Calandra,et al.  Antibiotics in sepsis , 2001, Intensive Care Medicine.

[30]  J. Tokars,et al.  A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. , 2000, The Journal of infectious diseases.

[31]  L. McDonald,et al.  Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries , 1999, The Lancet.

[32]  F. Wabwire-mangen,et al.  A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[33]  Leibovici,et al.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.

[34]  L. Reller,et al.  Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  M. Peeters,et al.  Presence of multiple non‐B subtypes and divergent subtype B strains of HIV‐1 in individuals infected after overseas deployment , 1997, AIDS.

[36]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[37]  A. Zaritsky,et al.  Role of early fluid resuscitation in pediatric septic shock. , 1991, JAMA.

[38]  D. Warrell,et al.  Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya , 1990, The Lancet.

[39]  L. Laliberte,et al.  The Karnofsky performance status scale: An examination of its reliability and validity in a research setting , 1984, Cancer.

[40]  D. Karnofsky.  Meaningful clinical classification of therapeutic responses to anticancer drugs , 1961, Clinical pharmacology and therapeutics.

[41]  M. Molyneux,et al.  Bacteraemia and mortality among adult medical admissions in Malawi--predominance of non-typhi salmonellae and Streptococcus pneumoniae. , 2001, The Journal of infection.

[42]  A. Grant,et al.  Natural history and spectrum of disease in adults with HIV/AIDS in Africa. , 1997, AIDS.